PetVivo Holdings, Inc. Announces Executive Changes
September 14, 2021 at 06:51 pm IST
Share
On September 9, 2021, the Company appointed Randall Meyer to serve as the Chief Operating Officer of PetVivo Holdings, Inc. Mr. Meyer has served as a director of the Company since April 2015. He previously served as the Chief Operating Officer of Gel-Del Technologies, Inc., from January 2009 to April 2015 and as the Chief Operating Officer of the Company from April 2015 to November 2017. On September 9, 2021, the Company appointed John Dolan to serve as the Chief Business Development Officer of the Company. Mr. Dolan currently serves as the Company’s General Counsel and Secretary. He also has served as a director of the Company since March 2014.
PetVivo Holdings, Inc. is a biomedical device company. The Company is focused on the manufacturing, commercialization, and licensing of medical devices and therapeutics for animals. The Companyâs lead product Spryng with OsteoCushion Technology, is a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The Company is primarily engaged in the business of commercializing and licensing products in the veterinary market to treat and/or manage afflictions of companion animals, such as dogs and horses. Its products are derived from biomaterials that simulate a bodyâs cellular tissue by virtue of their reliance upon natural protein and carbohydrate compositions, which incorporate such tissue building blocks as collagen, elastin, and proteoglycans such as heparin. The Company has a pipeline of therapeutic devices for both veterinary and human clinical applications.
PETVIVO HOLDINGS, INC. 
